Women in Biotech - London

Wednesday 4 March 2020

This March our Women in Biotech series returns to London, scheduled for the same week as International Women’s Day 2020. Join us for an excellent evening of networking, drinks, and thought-provoking discussion.

The BIA are delighted to welcome speakers from an exciting new project at our Women in Biotech event this March. Join us on Wednesday 4 March to hear about Women Ahead of Their Time (WATT).



18.00   Registration and networking

18.30   Welcome
Jane Wall, Director of Business Development and Membership Services, BIA
               TBC, Bird & Bird

18.40   Guest speaker - Ursula Ney, Non-Executive Director, Proteome Sciences

18.50   Introduction to Women Ahead of Their Time (WATT) - Agnieszka Wabik, Co-founder, WATT

18.55   Panel discussion and Q&A
              Ursula Ney, Non-Executive Director, Proteome Sciences
              Jessica Santivanez, Senior Scientist, GSK
              Silvia De Alessandris, Manager in Healthcare and Life Sciences strategy, KPMG UK

19.30   Closing remarks

19.35   Networking and drinks

21:00   Close


Bird & Bird LLP
12 New Fetter Lane

Transport: The venue is in central London and easily reached by public transport. It is within 10 minutes walk of Chancery Lane, Temple, and Blackfriars stations. 

Costs and T&Cs

BIA members - £30 +VAT
Non-members - £40 +VAT

By registering to this event you accept our Terms & Conditions

If you have any questions or problems registering, please contact biaevents@bioindustry.org 

Women Ahead of Their Time (WATT) 

WATT is a new not-for-profit organisation aimed at inspiring younger generations by showcasing stories of female professionals in their early stage careers in STEM. Through WATT, these extraordinary women share with the world their unique journey to success, including the struggles and failures along the way.

There is no magic recipe for success, but passion and determination are a commonplace. Join the WATT team at the BIA Women in Biotech event for the official launch of the website and panel discussion with young professionals in bioindustry.  


Dr Ursula Ney

Non-Executive Director

Proteome Sciences plc

Dr Ursula Ney has more than 30 years’ experience in the pharmaceutical industry including 20 years’ experience of leadership roles in the biotech sector with responsibilities for operations in the UK and the US covering drug development, licensing and partnering. Ursula has extensive experience of working on public and private Boards, both in an executive and non-executive capacity. She was an executive Director of Celltech plc and Antisoma plc and CEO of Genkyotex and is currently a non-executive director at Proteome Sciences plc and a Trustee of the University of Plymouth. Her early career was spent at Sandoz (Switzerland) then Roche (UK).

Ursula has a BSc with Hons in Pharmacology from Chelsea College, University of London, a PhD from the Royal Free Hospital Medical School and an MBA from Middlesex University Business School. She recently obtained an MA in Modern History at King’s College, London.

Agnieszka Wabik



Agnieszka is a co-founder of WATT. She completed a PhD at the University of Cambridge focusing on early cancer development. She was supporting the development and implementation of the scientific strategy while working at the Experimental Cancer Medicines Centres Network at Cancer Research UK. Currently, she works as a freelance scientific consultant for Inspiralia, coordinating multidisciplinary teams to help formulate innovation strategy and fundraising for biotechnology start-ups and scientific partnerships.

Jessica Santivanez

Senior Scientist


Jessica is a Senior Scientist at GSK with strong expertise in assay development for early drug discovery. She has rotated across functions to work with small molecules, biopharms and data science. Before transitioning to the pharmaceutical industry, she completed a PhD at the University of Cambridge focusing on neurodegeneration research.

Silvia De Alessandris

Manager in Healthcare and Life Sciences strategy


Silvia is a biotechnologist by background. After her PhD at the University of Cambridge, a collaboration with biotech company MedImmune Ltd, attracted by the interface between science and business, she decided to make a career in strategy consulting. For the last 4 years Silvia has supported Top 20 pharmaceutical companies with their commercialisation and growth strategies, specialising in pricing and market access of novel therapies.

The BIA’s Women in Biotech event series has been running for over 12 years and aims to connect, inspire, and support women across the sector.


Thank you to our host and Women in Biotech series sponsor



BIA Annual Supporters